1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.
2. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (HHS publication No. PEP21–07–01–003, NSDUH Series H–56). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2021. Retrieved from https://www.samhsa.gov/data/report/2020-nsduh-annual-national-report.
3. Mental Illness: National Institute of Mental Health 2022 [Available from: https://www.nimh.nih.gov/health/statistics/mental-illness#part_2538. Accessed 26 April 2022.
4. Evans TS, Berkman N, Brown C, Gaynes B, Weber RP. AHRQ comparative effectiveness technical briefs. Disparities Within Serious Mental Illness. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016
5. Janssen EM, McGinty EE, Azrin ST, Juliano-Bult D, Daumit GL. Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness. Gen Hosp Psychiatry. 2015;37(3):199–222.